Ligand Pharmaceuticals Inc (LGND)
114.58
+0.64
(+0.56%)
USD |
NASDAQ |
Dec 20, 16:00
115.00
+0.42
(+0.37%)
After-Hours: 20:00
Ligand Pharmaceuticals Shareholders Equity (Quarterly): 841.18M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cellectar Biosciences Inc | 15.16M |
| Revance Therapeutics Inc | -163.03M |
| Pieris Pharmaceuticals Inc | 16.27M |
| Zymeworks Inc | 366.98M |
| CNS Pharmaceuticals Inc | 3.352M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 954.87M |
| Total Liabilities (Quarterly) | 113.69M |
| Current Ratio | 12.49 |